| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.9 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.027 | 0.9 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.9 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.0098 | 0.9 |